Physician profile
Stacey Rifkin-Zenenberg
NPI 1376519157
$18,662.85
in general payments reported to CMS, 2019-2025
9 companies · $6,790 in 2025
The $6,790 reported for 2025 was more than what 99% of Hospice and Palliative Medicine (Pediatrics) providers received nationally (typical 2025 total: $50.56).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2021: $2,249 · 2022: $4,484 · 2023: $4,970 · 2024: $35.67 · 2025: $6,790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $5,425 · Consulting Fee: $4,200 · Travel and Lodging: $1,201 · Food and Beverage: $969.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $5,425.00 |
| Consulting Fee | $4,200.00 |
| Travel and Lodging | $1,200.85 |
| Food and Beverage | $969.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Global Blood Therapeutics, INC. | $6,732.86 | 2021-2022 | |
| Genetix Biotherapeutics INC | $6,573.44 | 2025 | Lyfgenia |
| Vertex Pharmaceuticals Incorporated | $4,839.58 | 2023 | |
| Genzyme Corporation | $199.85 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $134.97 | 2019 | |
| Novo Nordisk INC | $124.81 | 2025 | |
| Rare Disease Therapeutics, INC. | $22.75 | 2025 | Xromi |
| Pfizer INC. | $18.99 | 2025 | |
| Medunik USA INC. | $15.60 | 2024 | Siklos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Rifkin-Zenenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.